29.05.2014
- US drugmaker Eli Lilly has struck a licensing deal with Sanofi that would allow its French rival to pursue regulatory approval for a non-prescription version of Lilly's erectile...
08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
07.05.2014
- As expected, Germany's Bayer has emerged as the winner of the race to acquire U.S. Merck's consumer care business. The $14.2 billion deal announced on May 5 is expected to close in...
30.04.2014
- French pharmaceutical producer Sanofi is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, the news agency Reuters said, quoting...
28.04.2014
- Germany's Bayer and British consumer products giant Reckitt are said to have emerged as frontrunners to win the auction for the Merck & Co consumer products unit, each reportedly...
23.04.2014
- In one of several deals announced just after Easter, Swiss drugmaker Novartis said it would sell its animal health arm to U.S. rival Eli Lilly for about $5.4 billion. Lilly said...
22.04.2014
- A former executive of French drugmaker Sanofi, Mark Cupo, has been sentenced to 16 months in prison in the U.S. for insider trading, after cooperating with prosecutors. A judge in...
03.04.2014
- Sanofi is on the lookout for acquisitions to boost key business units such as consumer and animal health products and expects strong growth on the "strategic continent" of Africa...
24.03.2014
- French drugmaker Sanofi has agreed to form a three-year strategic partnership on drug development with Ludwig-Maximilians-University and the university clinic of Munich, Germany...
21.03.2014
- Novo Nordisk should still be able to introduce its long-acting insulin Tresiba on the U.S. market before rival products, despite being hit by a delay, the CEO of the Danish...